Dashboard

iCAD, Inc. (ICAD)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity

S

Analyst Opinion

B

Leverage & Liquidity

B

Fundamental Variables

S

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

iCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment include image analysis and workflow products. The Cancer Therapy segment consists radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.

CEO

Michael S. Klein

Employees

138

Industry

Specialized Medical Devices

Sector

Healthcare

Headquarters

Nashua

Exchange

NASDAQ

Summary Stats

Market Cap

30.4M

Revenue

32.3M

Net Income

-13M

EPS

-$0.52

Price-to-Earnings

-2.32

Price-to-Book

0.74

Debt-to-Equity

0.42

News

Analyst Ratings

Price targets projected by 5 analysts

High

$16.00

Average

$14.70

Low

$13.00

Ratings calculated by 5 analysts

Buy

5

Hold

0

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q3 2022

Last Earnings

Missed by -$0.02

Actual

-$0.15 -15.4%

Consensus

-0.13

Report Date

Year Ago

-0.09

Year Ago Change %

Down 66%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites